Patents Assigned to ImVisioN GmbH
  • Patent number: 7563866
    Abstract: Modular antigen transporter molecules (MAT molecules), which are used as vaccines and for the treatment of allergies, include three modules: a translocation module which brings about transport of the MAT molecule into the interior of the cell; a targeting module which directs the MAT molecule to intracellular organelles involved in antigen processing and loading; and an antigen module which contains an allergen.
    Type: Grant
    Filed: April 11, 2005
    Date of Patent: July 21, 2009
    Assignee: ImVisioN GmbH
    Inventors: Norbert Lamping, Reto Crameri, Sabine Fluckiger, Isabelle Daigle
  • Publication number: 20090117136
    Abstract: Dander from the domestic cat (Felis domesticus) is one of the most common causes of IgE mediated allergy. The present invention relates to a recombinant folded Fel d 1 with molecular and biological properties similar to the natural counterpart and specifically a synthetic gene coding for a direct fusion of Fel d 1 chain 2 N-terminally to chain 1. E coli expression resulted in a non-covalently associated homodimer with an apparent molecular weight of 30 kDa defined by size exclusion chromatography, each 19177 Da subunit displayed a disulfide pattern identical to that found in the natural Fel d 1, and having identical fold of natural and recombinant Fel d 1. The, recombinant Fel d 1 provides for diagnosis and allergen specific immunotherapy of cat allergy.
    Type: Application
    Filed: April 22, 2004
    Publication date: May 7, 2009
    Applicant: ImVisioN GmbH
    Inventors: Hans Gronlund, Marianne van Hage